What Researchers Did
Researchers prospectively evaluated the effect of hyperbaric oxygen (HBO2) on the healing of chronic lower extremity wounds in ten insulin-dependent diabetic patients, comparing five patients who received HBO2 to five controls over 7 weeks.
What They Found
At the end of 7 weeks, the hyperbaric oxygen (HBO2) group showed a significantly greater reduction in wound surface area compared to the control group (P < 0.05). Specifically, the mean wound area, expressed as a percentage of pretreatment baseline, was significantly reduced in patients receiving HBO2 treatment.
What This Means for Canadian Patients
For Canadian patients with chronic diabetic lower extremity wounds, hyperbaric oxygen therapy may offer a beneficial treatment option to promote wound healing and reduce wound size. This could potentially lead to improved outcomes and a better quality of life for those struggling with non-healing diabetic wounds.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada, nor did it involve Canadian researchers or participants.
Study Limitations
Key limitations of this study include its small sample size of ten patients and its non-randomized design, which may limit the generalizability of the findings.